• Liquid biopsy test confirms remission in HPV-associated oral cancer

    27 days ago - By Healio

    A novel liquid biopsy test showed compelling specificity and sensitivity in detecting HPV DNA among patients who underwent chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the American Society for Radiation Oncology Annual Meeting.
    “This blood test has exceptional performance in monitoring patients for cancer recurrence after radiation therapy,” Bhisham Chera, MD, an associate professor of radiation oncology at The University of North Carolina at Chapel Hill and a member of the UNC Lineberger Comprehensive Cancer Center,
    Read more ...

     

  • Cisplatin with radiation ‘standard of care' for HPV-related oral cancers

    27 days ago - By Healio

    Chemoradiotherapy produced superior survival outcomes compared with radiation and cetuximab in a cohort of patients with HPV-associated oropharyngeal cancer, according to randomized, phase 3 trial results presented at the American Society for Radiation Oncology Annual Meeting.
    “We've now established that high-dose cisplatin chemotherapy - in combination with radiation - is the standard of care for HPV-related oral cancers,” Andy Trotti, MD, a radiation oncologist at Moffitt Cancer Center and co-lead investigator of the NRG Oncology/RTOG 1016 study, said in a press
    Read more ...

     

  • Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer

    27 days ago - By Medscape

    A plasma circulating tumor human papillomavirus DNA test had a negative predictive value of 100% and predicts patients at risk for cancer recurrence.
    Medscape Medical News
    Read more ...